Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chinese Distributor Of Counterfeit Pharmaceuticals Sentenced To Prison For 78 Months, $1.286 Million In Restitution To Pfizer And Lilly

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - The 5th Circuit U.S. Court of Appeals re-sentenced Kevin Xu, owner of Pacific Orient International, a pharmaceutical distributor in China, to prison for conspiring to distribute counterfeit and misbranded drugs, United States Attorney José Angel Moreno announced April 23

You may also be interested in...



IFPMA Outlines Plan For Fighting Counterfeit Drugs

HONG KONG - The threat of counterfeit anti-infective drugs is rising rapidly, even as pharmaceutical companies, regulators and industry associations develop new strategies to deal with the problem

IFPMA Outlines Plan For Fighting Counterfeit Drugs

HONG KONG - The threat of counterfeit anti-infective drugs is rising rapidly, even as pharmaceutical companies, regulators and industry associations develop new strategies to deal with the problem

China's SFDA Launches Inspection Campaign To Ferret Out Fake Drugs Sold In Retail Outlets

SHANGHAI - China's State FDA together with the Ministry Of Health launched nationwide inspections this month in retail pharmacies to sweep out non-pharmaceutical products that are marketed as medicines, the agency announced Nov. 11

Related Content

UsernamePublicRestriction

Register

LL1132999

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel